Evolent Health (NYSE:EVH) Q4 2025 Earnings call February 24, 2026 05:00 PM ET Speaker9Welcome to the Evolent Earnings Conference Call for the fourth quarter ended December 31st, 2025. As a reminder, this conference call is being recorded. Your hosts for today's call are Seth Blackley, Chief Executive Officer, and John Johnson, Chief Financial Officer. This call will be archived and available later this evening and for the next week via the webcast on the company's website in the section titled Investor Rela ...

NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period"), of the important March 9, 2026 lead plaintiff deadline. So What: If you purchased Ardent Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. W ...

Evolent Health, Inc. Fourth Quarter 2025 Results February 24, 2026 Evolent | Confidential—Do not distribute | 1 Safe Harbor Statement Certain statements made in this report and in other written or oral statements made by us or on our behalf are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 ("PSLRA"). A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any statement that may predict, forecast, ind ...

HEALTH, INC.CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) ( in thousands, except per share data)For the Three Months Ended December 31,For the Year Ended December 31,2025202420252024Revenue$ 468,719$ 646,542$ 1,876,229$ 2,554,741ExpensesCost of revenue371,466570,8311,476,3462,187,388Selling, general and administrative expenses72,65647,701303,866263,050Depreciation and amortization expenses45,03729,296115,851118,370Loss on lease termination—18,92267618,922Gain on disposal of non- stra ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on March 9, 2026, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - Investors who bought Ardent Health securities between July 18, 2024, and November 12, 2025, may be eligible for compensation through a class action lawsuit [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5]. - The deadline to move the Court to serve as lead plaintiff is March 9, 2026, which is crucial for those wishing to represent other class members [2]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in this area [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in terms of settlements [3]. - In 2019, Rosen Law Firm secured over $438 million for investors, showcasing their capability in recovering funds for clients [3]. Group 3: Case Allegations - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable and the processes used to determine their collectability [4]. - Defendants claimed to employ an active monitoring process for accounts receivable, which was later revealed to be inaccurate, as they did not primarily rely on detailed reviews [4]. - The firm also misrepresented its professional malpractice liability insurance coverage, which was insufficient to cover claims, particularly in the New Mexico market [4].

Group 1: Software Stocks Performance - Major indices were boosted by significant increases in software-related stocks, with Salesforce and ServiceNow both rising by 3% and the iShares Expanded Tech – Software Sector ETF (IGV) gaining 2%, although it remains over 30% lower than its 52-week peak [1] - Retail clients are cautious and waiting for new AI product announcements, interpreting news about Anthropic as competition for legacy applications, which has contributed to a less aggressive market upturn [2] Group 2: Earnings Season Insights - Home Depot exceeded expectations for its fourth quarter, reporting better EPS and revenue, leading to a 2.7% increase in its stock [3] - Keysight Technologies experienced a significant stock surge of 15% after reporting better earnings per share and revenue, while Hims & Hers Health's stock fell nearly 7% due to lower than expected first quarter revenue guidance [4] - Diamondback Energy's stock declined by 3% following the release of lower than expected adjusted earnings [4] Group 3: Economic Concerns - The 10% tariff imposed by the U.S. has raised concerns about its impact on other economies, with speculation that President Trump may increase the tariff to 15%, leading to a risk-averse stance among investors [5]

Across the private portfolio, management reported aggregate Q4 revenue growth of nearly 12% and full-year revenue growth of 15% , while EBITDA rose nearly 18% in Q4 and 28.6% for the full year . Operating cash flow for the large portfolio companies increased 15%, and aggregate cash balances were up about 25% year-over-year, according to the presentation.In Q4, management said the increase was driven by a 10%+ share price rise in Lion Finance Group and 3.5% growth in the private large portfolio companies. Bu ...

2025 net revenues increased 5.7% to $1.164 billion, compared to 2024, or 5.2% on a constant currency basis2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or $0.16 per diluted share, in 20242025 Adjusted EBITDA(1) increased 8.2% to $594 million, compared to 2024, or 7.8% on a constant currency basis2025 Adjusted EPS(1) of $0.86, an increase of $0.16 per diluted share, compared to 2024Full-year 2026 outlook: net revenues growth of 5.0% to 6.5% and Ad ...

Core Insights - CLEAR collaborates with Mount Sinai Health System to enhance digital experiences for patients and employees, marking Mount Sinai as the first health system in New York City to deploy CLEAR1, a secure identity platform [1][2][3] Company Overview - CLEAR is a secure identity company with a mission to create safer and easier everyday experiences by connecting individuals to their secure identity [4][7] - Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, employing 48,000 staff across seven hospitals and over 400 outpatient practices [8][9] Technology Implementation - CLEAR1 will provide a unified identity across the Mount Sinai ecosystem, facilitating a seamless identity experience for both employees and patients [2][3] - The platform integrates with core healthcare systems such as EHRs and patient portals, streamlining account creation and access, which has previously led to increased digital check-in adoption and reduced duplicate records [5] Security and Standards - CLEAR1 is certified by the Kantara Initiative for NIST Identity Assurance Level 2 (IAL2) and Authenticator Assurance Level 2 (AAL2), ensuring high-assurance standards for trusted healthcare data exchange [6]

New York, New York--(Newsfile Corp. - February 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period"), of the important March 9, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardent Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency ...